Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 4.


Rosadas, Carolina, Khan, Maryam, Parker, Eleanor, Marchesin, Federica, Katsanovskaja, Ksenia, Sureda-Vives, Macia, Fernandez, Natalia, Randell, Paul, Harvey, Ruth, Lilley, Alice
et al (show 28 more authors) (2022) Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility. JOURNAL OF VIROLOGICAL METHODS, 302. 114475-.


Emary, Katherine RW, Golubchik, Tanya, Aley, Parvinder K, Ariani, Cristina V, Angus, Brian, Bibi, Sagida, Blane, Beth, Bonsall, David, Cicconi, Paola, Charlton, Sue
et al (show 57 more authors) (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. LANCET, 397 (10282). pp. 1351-1362.


Puksuriwong, Suttida, Ahmed, Muhammad S ORCID: 0000-0001-6163-8102, Sharma, Ravi, Krishnan, Madhan, Leong, Sam, Lambe, Teresa, McNamara, Paul S ORCID: 0000-0002-7055-6034, Gilbert, Sarah C and Zhang, Qibo
(2020) Modified Vaccinia Ankara–Vectored Vaccine Expressing Nucleoprotein and Matrix Protein 1 (M1) Activates Mucosal M1-Specific T-Cell Immunity and Tissue-Resident Memory T Cells in Human Nasopharynx-Associated Lymphoid Tissue. The Journal of infectious diseases, 222 (5). pp. 807-819.


Folegatti, Pedro M, Ewer, Katie J, Aley, Parvinder K, Angus, Brian, Becker, Stephan, Belij-Rammerstorfer, Sandra, Bellamy, Duncan, Bibi, Sagida, Bittaye, Mustapha, Clutterbuck, Elizabeth A
et al (show 22 more authors) (2020) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. LANCET, 396 (10249). pp. 467-478.

This list was generated on Sat Apr 13 05:26:13 2024 BST.